VERNON W ANTHONY 4
4 · NovoCure Ltd · Filed Jun 9, 2023
Insider Transaction Report
Form 4
NovoCure LtdNVCR
VERNON W ANTHONY
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-07+6,277→ 6,277 totalExercise: $48.66From: 2024-06-07Exp: 2033-06-06→ Ordinary Shares (6,277 underlying) - Award
Restricted Stock Units
2023-06-07+3,853→ 165,797 total
Footnotes (2)
- [F1]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders.
- [F2]Options to buy 6,277 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2024 annual general meeting of shareholders.